New cancer drug trial seeks to control advanced tumors
Disease control
Terminated
This study tested a new drug called THOR-707, both by itself and combined with other cancer therapies, in adults with advanced or spreading solid tumors. The main goals were to find safe and effective doses and to see if the treatment could shrink tumors. The trial has been termi…
Phase: PHASE1, PHASE2 • Sponsor: Synthorx, Inc, a Sanofi company • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC